scholarly journals The development of health insurance system in China in the period of socialist modernization (1978 – 2001)

2020 ◽  
pp. 36-50
Author(s):  
Khentsze Lyu
Keyword(s):  
Health Insurance ◽  
Urban Areas ◽  
Medical Services ◽  
Health Insurance System ◽  
Market Mechanisms ◽  
Insurance System ◽  
Cost Treatment ◽  
Personal Savings ◽  
The Cost ◽  
The City

  This article explores the development of health insurance system in China over the period from 1978 to 2001. The author reviews the implementation of market mechanisms in health insurance system; provides statistical data on the number of insured persons residing in the city or rural localities. Analysis is conducted on legislation that regulates insurance activity in the sphere of medicine. The conclusion is made that the implementation of such systems affected by migration from rural to urban areas led to imbalance in the quality and availability of medical services. It is noted that despite the efforts of Chinese authorities, health insurance system did not expand neither the number of insured rural or urban residents; dependence of the level of medical care on the level of salaries led to segregation of rich and poor citizens. The employees with insufficient salary level were trying to reduce the cost treatment, as it partially compensated from their personal savings, which also led to severe sanitary consequences. Therefore, the implementation of market mechanisms in health insurance led to inequality of the citizens with regards to availability of medical services.  

scholarly journals Economic aspects of the use of innovative methods of stationary medical services payment in obligatory health insurance system

2016 ◽  
pp. 39-42
Author(s):  
Natalia Vladimirovna Bryksina ◽  
◽  
Mikhail Yurievich Klyuchnikov ◽  
Olga Vladimirovna Alenicheva ◽  
◽  
...  
Keyword(s):  
Health Insurance ◽  
Medical Services ◽  
Economic Aspects ◽  
Health Insurance System ◽  
Insurance System ◽  
Innovative Methods

scholarly journals Cost-Effectiveness of Contraceptive Use in Indonesia after the Implementation of the National Health Insurance System

2021 ◽  
Vol 2021 ◽  
pp. 1-6
Author(s):  
Auliya A. Suwantika ◽  
Neily Zakiyah ◽  
Irma M. Puspitasari ◽  
Rizky Abdulah
Keyword(s):  
Health Insurance ◽  
Cost Effectiveness ◽  
National Health Insurance ◽  
National Health ◽  
Contraceptive Use ◽  
Intrauterine Device ◽  
Health Insurance System ◽  
National Health Insurance System ◽  
Insurance System ◽  
The Cost

Since 2014, Indonesia has initiated to implement a national health insurance system, which included both of short- (SARC) and long-acting reversible contraceptive (LARC) into the benefit package. The aim of this study was to analyze the cost-effectiveness of contraceptive use in Indonesia after the implementation of the national health insurance in 2014-2017. A decision tree model was developed to analyze the cost-effectiveness of contraceptive use in Indonesia in 2014-2017 by comparing two strategies of pregnancy prevention: contraceptive and non-contraceptive. For contraceptive strategy, we took into account SARC and LARC. In a comparison with non-contraceptive, we calculated that the incremental cost-effectiveness ratio (ICER) of SARC would be $5.18, $4.80 and $3.76 per pregnancy averted for injection, condom, and pill, respectively. For LARC, we calculated that the ICER would be $1.67 and $0.84 for implant and intrauterine device (IUD), respectively, compared with non-contraceptive. In general, the cost-effectiveness value of LARC ($1.25) was much better than SARC ($4.58). The cost of contraceptive was considered to be the most influential parameter affecting both the ICER of SARC and LARC. In conclusion, the use of LARC in Indonesia was considered to be more cost-effective than SARC since the implementation of national health insurance system. In particular, IUD yielded the greatest cost-effectiveness value, compared with other methods.

scholarly journals Problems and prospect of development of health insurance system in China

2020 ◽  
pp. 11-16
Author(s):  
Khentsze Lyu
Keyword(s):  
Health Insurance ◽  
Insurance Coverage ◽  
Quality Of Healthcare ◽  
Healthcare Services ◽  
Medical Services ◽  
Health Insurance System ◽  
Insurance System ◽  
Guaranteed Service ◽  
State Subsidies

This article examines the current health insurance system in China. Emphasis is made on determination of the key features and peculiarities of Chinese health insurance system, as well as its flaws and ways for overcoming them. The author believes that resolution of major issues in Chinese health insurance system requires increased state involvement thereof, since the marked-based approach that has been in effect for the past 30 years lead to inequality and deterioration of the quality of healthcare. The following recommendations are made on the improvement of health insurance system: launch the targeted financing projects that would allow the citizens with especially dangerous diseases, such as cardiovascular, oncological, digestive and nervous system, diabetes, to be paid in full by insurance and state subsidies in receiving medical services and medications; forgo the principle of “annual limit” for medical services and medications under insurance coverage; unify insurance payment systems in different regions in order to improve the quality of rendering healthcare services in poor areas. The author also offers to consider the possibility of implementation of the universal guaranteed service standards that would ensure equal level of the quality of basic services regardless the type of insurance.

scholarly journals Cost-Effectiveness and Budget Impact Analysis of Apatinib for Advanced Metastatic Gastric Cancer from the Perspective of Health Insurance System

2017 ◽  
Vol 2017 ◽  
pp. 1-7 ◽  
Author(s):  
Yongrui Bai ◽  
Yuejuan Xu ◽  
Bin Wu
Keyword(s):  
Gastric Cancer ◽  
Health Insurance ◽  
Cost Effectiveness ◽  
Impact Analysis ◽  
Budget Impact ◽  
Metastatic Gastric Cancer ◽  
Sensitivity Analyses ◽  
Health Insurance System ◽  
Insurance System ◽  
The Cost

Objective. This study evaluated the cost-effectiveness of apatinib in patients with chemotherapy-refractory mGC. Patients and Methods. A Markov model was developed to simulate the clinical course of typical patients with chemotherapy-refractory metastatic gastric cancer (mGC). We estimated the 10-year quality-adjusted life-years (QALY), costs, and incremental cost-effectiveness ratios (ICER). Model inputs were derived from the published literature and government sources. Direct costs were estimated from the perspective of the Chinese health insurance system. A scenario analysis for a Patient Assistance Programme (PAP) was performed. Results. Baseline analysis showed that apatinib increased the cost and QALYs by $7859 and 0.192, respectively, relative to conventional chemotherapy, resulting in an ICER of $40,997/QALY gained. When PAP was available, the ICER was $21,132/QALY. Probabilistic sensitivity analyses confirmed that apatinib with PAP achieved nearly 65% likelihood of cost-effectiveness at the threshold of $22,200. One-way sensitivity analyses demonstrated that the utility of progression-free survival was the most influential factor on the robustness of the model. Budget impact analysis estimated that the annual increase in fiscal expenditures would be approximately 0.45 million dollars. Conclusions. Our analysis suggests that apatinib is likely cost-effective in patients with chemotherapy-refractory mGC when PAP is available.

scholarly journals Factors Associated with Access of Marital Migrants and Migrant Workers to Healthcare in Taiwan: A Questionnaire Survey with Quantitative Analysis

2019 ◽  
Vol 16 (16) ◽  
pp. 2830 ◽  
Author(s):  
Feng-Yuan Chu ◽  
Hsiao-Ting Chang ◽  
Chung-Liang Shih ◽  
Cherng-Jye Jeng ◽  
Tzeng-Ji Chen ◽  
...  
Keyword(s):  
Health Insurance ◽  
Migrant Workers ◽  
Point Of Care ◽  
Language Barriers ◽  
Medical Services ◽  
Health Insurance System ◽  
National Health Insurance System ◽  
Cross Sectional ◽  
Insurance System ◽  
Factors Associated

In Taiwan, migrants come mostly for marriage and work. Several researchers have conducted health-related studies of marital migrants and migrant workers, but the access of the two groups to healthcare has not been studied. Therefore, our study investigated the factors associated with migrants’ access to healthcare, with the main foci being marital migrants and migrant workers in Taiwan. A structured and cross-sectional questionnaire was anonymously self-administered by migrants recruited to participate in this survey on a voluntary basis from 11 medical centers and 11 migrant-helping associations in Taiwan between May 1st and September 21st, 2018. A total of 753 questionnaires were analyzed. The majority of marital migrants (n = 243) and migrant workers (n = 449) surveyed were enrolled in Taiwan’s National Health Insurance system (92.7 vs. 93.5%, p = 0.68). More of the migrant workers (n = 205) than the marital migrants (n = 42) encountered language barriers while seeking medical services (48.0 vs. 17.1%, p < 0.001). A professional interpreter at the point of care was considered important by more of the migrant workers (n = 316) than the marital migrants (n = 89) (70.2 vs. 39.6%, p < 0.001). Although more than 90% of the surveyed migrants were enrolled in the health insurance system in Taiwan, many, especially among the migrant workers, still faced language barriers while seeking medical services.

Sign in / Sign up

Export Citation Format

Share Document